Assuming it is next step "Approval" by FDA following prelisting with "Clearance" status, expect should give medical world increased confidence and bode well for product expansion particularly in American market, which will hopefully be reflected in rerated share price. Thurs could be interesting!
Assuming it is next step "Approval" by FDA following prelisting...
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
0.005(0.95%) |
Mkt cap ! $217.5M | |||
| Open | High | Low | Value | Volume |
| 52.5¢ | 53.0¢ | 52.0¢ | $247.0K | 471.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 88057 | 52.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.0¢ | 19046 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |